Welcome to Acidity Regulator Quarterly China Report—Q2 2025
Market Analysis:
On 8 May, 2025, India's Ministry of Finance, Department of Revenue issued Notification No. 10/2025-Customs(ADD), accepting the affirmative final ruling of the second sunset review investigation by India's Directorate General of Trade Remedies (DGTR) on 12 Feb., 2025 regarding sodium citrate originating in or imported from China.
Company Dynamics:
- On 23 April, 2025, Huaheng Biotech released its annual report for the year 2024. By Q1 2025, Huaheng Biotech has seen a decline in net profit for four consecutive quarters; facing performance pressure, Huaheng Biotech is accelerating the industrial application of synthetic biology technology.
- In early May 2025, Jindan Tech commissioned its 50,000 t/a refined lactic acid project.
- On 25 June, 2025, Shandong Ensign announced that due to the company's business development and production and operation needs, it plans to apply for a renewal loan of no more than USD62.91 million (RMB450.00 million) from the Shandong Branch of the Export-Import Bank of China with which it cooperates.
In Q2 2025, domestic citric-acid price flattened in April, slipped gently through May, and steadied in June 2025, cushioned by cost support.
The USD/CNY exchange rate in this period is 7.1534, sourced from the People's Bank of China on 1 July, 2025. Except for special instructions, all prices involved in this period include VAT.

